Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Planned Job Reductions min:
Planned Job Reductions max:
Type of Restructuring:
Employment Effect Start:
The French subsidiary of US Pharmaeutical group Lilly has announced it will cut about 158 jobs. The group explained that due to a "particularly difficult economic and regulatory environment", Lilly France has "to safeguard its competitiveness". Lilly France has presented to its employee representatives a reorganization plan for the pharmaceutical sales unit which will be implemented from September 2015. This project would lead to the cut "of 158 positions, including 143 posts of medical sales representatives (out of a total of 378 positions), 14 regional director positions and 1 network manager".